Category: News

  • Clinical Potential of Polyphenols for ADHD

    Clinical Potential of Polyphenols for ADHD

    Published on 26/01/2024 in International Journal of Molecular Sciences Key Points However, further research is needed to establish the clinical potential of polyphenols, particularly in adult populations, and to explore different types of polyphenols. Building the Case: Polyphenols for ADHD This systematic review explored the potential use of polyphenols as innovative therapeutic strategies for the…

  • Mild Traumatic Brain Injuries Risk Affective & Behavior Disorders

    Mild Traumatic Brain Injuries Risk Affective & Behavior Disorders

    Published on 25/01/2024 in AAP Paediatrics Highlights Synopsis The study aimed to address the limitations of previous research by determining the incidence and relative risk of post-injury affective and behavioral disorders 4 years after mild traumatic brain injuries (mTBIs) in children. The cohort study included 18,917 mTBI cases and 37,834 matched comparisons within an integrated…

  • Stimulants in Pregnancy

    Stimulants in Pregnancy

    Published on 24/01/2024 in JAMA Psychiatry Key Points Stimulants for ADHD in Pregnancy The research study investigated the association between prescription stimulant treatment for attention-deficit/hyperactivity disorder (ADHD) during pregnancy and the risk of neurodevelopmental disorders in children. The study, which included 7065 pregnancies exposed to amphetamine/dextroamphetamine and 1123 pregnancies exposed to methylphenidate in the second…

  • Stimulant Use in ADHD with ASD and Psychosis: A Case Study

    Stimulant Use in ADHD with ASD and Psychosis: A Case Study

    Published on 31/01/2024 in Cureus The case study paper explores the association between autism spectrum disorder (ASD) and common mental health disorders, focusing on the prevalence of attention deficit hyperactivity disorder (ADHD) in individuals with ASD and the use of stimulant medications as a treatment. The paper presents a case study of a 13-year-old male…

  • Diagnostic Delays: When Waiting Room Time Feels Eternal

    Diagnostic Delays: When Waiting Room Time Feels Eternal

    What is diagnostic delay? The time between first acknowledgement of symptoms to final diagnosis. What are the various types of delays? 🔶PRIMARY DELAY:At the level of patient before first contact with Health provider 🔶SECONDARY DELAY:After contact with health care provider to actual correct diagnosis What has the latest research on diagnostic delay in ADHD and…

  • PNRS Approach Unveils Brain Dysconnectivity in ADHD

    PNRS Approach Unveils Brain Dysconnectivity in ADHD

    Neuroscience study published by researchers of Oregon Health & Science University, Portland, Oregon, USA suggests widespread dysconnectivity in ADHD brain. Objectives Researchers aimed to address the challenges of identifying replicable neuroimaging correlates of ADHD by focusing on the cumulative effects of resting-state connectivity across all brain networks. In simple terms, this study looked at how…

  • Puzzle of Age: Cognitive Decline or Missed ADHD?

    Puzzle of Age: Cognitive Decline or Missed ADHD?

    As we age, it’s natural to worry about memory loss and cognitive decline. However, George Keepers, MD, Chair and Professor of Psychiatry at Oregon Health Sciences School of Medicine, suggests that Attention Deficit Hyperactivity Disorder (ADHD) could play a role in some cases. This overlap between ADHD and aging raises important questions about how we…

  • Urgent Recall for Zenzedi® 30 mg Amidst Packaging Mix-Up

    Urgent Recall for Zenzedi® 30 mg Amidst Packaging Mix-Up

    On January 24, 2024, Azurity Pharmaceuticals, Inc., based in Woburn, Massachusetts, has initiated a voluntary recall of a specific lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg at the consumer level. This recall is prompted by a pharmacist in Nebraska who discovered Carbinoxamine Maleate, an antihistamine drug, in a bottle labeled as…

  • ADHD Stimulant Treatment Cuts Suicide Risk!

    ADHD Stimulant Treatment Cuts Suicide Risk!

    Published in BJPsych Open(Cambridge) on 22/01/2024 Suicide and the association of mental illness, particularly attention-deficit hyperactivity disorder (ADHD), with increased risk of suicide attempts and mortality is a significant public health concern in the USA. Traditional theories have focused on depression and isolation as primary risk factors for suicide, but there is a growing body…

  • Serious Consequences of Undiagnosed ADHD

    Serious Consequences of Undiagnosed ADHD

    Exposing the serious consequences of undiagnosed ADHD, this narrative calls urgently for early intervention. Unveil the shadows, protect vulnerable lives. Shadows of Undiagnosed ADHD In a compelling account recently featured on Your Tango, an intimate narrative unfolds, revealing the often-overlooked consequences of undiagnosed ADHD. The author courageously shares her childhood experiences, casting a sobering light…

You cannot copy content of this page